Key Insights

Highlights

Success Rate

86% trial completion

Published Results

36 trials with published results (14%)

Research Maturity

128 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.8%

20 terminated out of 255 trials

Success Rate

86.5%

-0.0% vs benchmark

Late-Stage Pipeline

15%

37 trials in Phase 3/4

Results Transparency

28%

36 of 128 completed with results

Key Signals

36 with results86% success20 terminated

Data Visualizations

Phase Distribution

179Total
Not Applicable (70)
Early P 1 (2)
P 1 (34)
P 2 (36)
P 3 (25)
P 4 (12)

Trial Status

Completed128
Unknown47
Recruiting33
Terminated20
Withdrawn10
Active Not Recruiting9

Trial Success Rate

86.5%

Benchmark: 86.5%

Based on 128 completed trials

Clinical Trials (255)

Showing 20 of 20 trials
NCT07570121Phase 1Not Yet Recruiting

Pharmacokinetics and Placental Transfer of Caffeine

NCT04107701CompletedPrimary

Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD

NCT06915441Phase 2RecruitingPrimary

Lipid Infusions to Optimize Nutrition Trial

NCT07561125Phase 2RecruitingPrimary

Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

NCT03701074Phase 2Terminated

Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus

NCT04184648CompletedPrimary

Comparison of Classification Standards of Bronchopulmonary Dysplasia (BPD) in Premature Infants

NCT07525167Not Yet RecruitingPrimary

Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data

NCT06925360Phase 2RecruitingPrimary

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

NCT03142568Phase 2CompletedPrimary

Safety of Sildenafil in Premature Infants

NCT06373289Not ApplicableRecruitingPrimary

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

NCT01648855Completed

Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn

NCT06589245Phase 1RecruitingPrimary

Inhaled Ciclesonide Study in Preterm Infants

NCT06808997Recruiting

Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates.

NCT03782610Active Not Recruiting

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

NCT06579157RecruitingPrimary

Pressure-Sensing Mattresses and Mechanical Ventilation Weaning in Neonatal

NCT07411261Not ApplicableNot Yet RecruitingPrimary

PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants

NCT04821453Not ApplicableTerminatedPrimary

NAVA vs. CMV Crossover in Severe BPD

NCT06897839Phase 2RecruitingPrimary

Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)

NCT04035629Phase 1WithdrawnPrimary

129Xe MRI in Pediatric Population With BPD

NCT02475434Not ApplicableCompletedPrimary

Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants

Scroll to load more

Research Network

Activity Timeline